442
Views
6
CrossRef citations to date
0
Altmetric
REVIEW

Treatment of Ventriculitis and Meningitis After Neurosurgery Caused by Carbapenem-Resistant Enterobacteriaceae (CRE): A Challenging Topic

, , &
Pages 3807-3818 | Received 12 Apr 2023, Accepted 08 Jun 2023, Published online: 15 Jun 2023

References

  • Li Z, Wu X, Yu J, et al. Empirical combination antibiotic therapy improves the outcome of nosocomial meningitis or ventriculitis in neuro-critical care unit patients. Surg Infect. 2016;17(4):465–472. doi:10.1089/sur.2015.060
  • Pintado V, Pazos R, Jiménez-Mejías ME, et al. Staphylococcus aureus meningitis in adults: a comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strains. J Hosp Infect. 2019;102(1):108–115. doi:10.1016/j.jhin.2018.11.008
  • Iwasaki Y, Inokuchi R, Harada S, et al. Bacterial meningitis caused by hypervirulent Klebsiella pneumoniae capsular genotype K54 with development of granuloma-like nodal enhancement in the brain during the subacute phase. Intern Med. 2017;56(3):373–376. doi:10.2169/internalmedicine.56.7384
  • Flint AC, Rao VA, Renda NC, Faigeles BS, Lasman TE, Sheridan W. A simple protocol to prevent external ventricular drain infections. Neurosurgery. 2013;72(6):993–999. doi:10.1227/NEU.0b013e31828e8dfd
  • Jamjoom AAB, Joannides AJ, Poon MT-C. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. J Neurol Neurosurg Psychiatry. 2018;89(2):120–126. doi:10.1136/jnnp-2017-316415
  • Bischoff P, Schröder C, Gastmeier P, et al. Surveillance of external ventricular drainage-associated meningitis and ventriculitis in German intensive care units. Infect Control Hosp Epidemiol. 2020;41:452–457. doi:10.1017/ice.2019.367
  • Hasbun R. Healthcare-associated ventriculitis: current and emerging diagnostic and treatment strategies. Expert Rev Anti Infect Ther. 2021;19(8):993–999. doi:10.1080/14787210.2021.1866544
  • Walek KW, Leary OP, Sastry R, et al. Risk factors and outcomes associated with external ventricular drain infections. Infect Control Hosp Epidemiol. 2022;43(12):1859–1866. doi:10.1017/ice.2022.23
  • Sorinola A, Buki A, Sandor J, Czeiter E. Risk factors of external ventricular drain infection: proposing a model for future studies. Front Neurol. 2019;10:226. doi:10.3389/fneur.2019.00226
  • Flint AC, Toossi S, Chan SL, Rao VA, Sheridan W. A simple infection control protocol durably reduces external ventricular drain infections to near-zero levels. World Neurosurg. 2017;99:518–523. doi:10.1016/j.wneu.2016.12.042
  • Schipmann S, Akalin E, Doods J, et al. When the infection hits the wound: matched case-control study in a neurosurgical patient collective including systematic literature review and risk factors analysis. World Neurosurg. 2016;95:178–189. doi:10.1016/j.wneu.2016.07.093
  • Jiménez-Martínez E, Cuervo G, Carratalà J. A care bundle intervention to prevent surgical site infections after a craniotomy. Clin Infect Dis. 2021;73(11):e3921–e3928. doi:10.1093/cid/ciaa884
  • Fang C, Zhu T, Zhang P, Xia L, Sun C. Risk factors of neurosurgical site infection after craniotomy: a systematic review and meta-analysis. Am J Infect Control. 2017;45(11):e123–e134. doi:10.1016/j.ajic.2017.06.009
  • Rosenthal VD, Richtmann R, Singh S, et al. International nosocomial infection control consortium. surgical site infections, international nosocomial infection control consortium (INICC) report, data summary of 30 countries, 2005–2010. Infect Control Hosp Epidemiol. 2013;34(6):597–604. doi:10.1086/670626
  • Gibson A, Kaplan S, Vallejo J, et al. Impact of serum vancomycin trough levels in the treatment of central nervous system shunt infections caused by coagulase-negative staphylococci. Pediatr Neurosurg. 2018;53(4):243–246. doi:10.1159/000488498
  • Hussein K, Bitterman R, Shofty B, et al. Management of post-neurosurgical meningitis: narrative review. Clin Microbiol Infect. 2017;23(9):621–628. doi:10.1016/j.cmi.2017.05.013
  • Panic H, Gjurasin B, Santini M, Kutlesa M, Papic N. Etiology and outcomes of healthcare-associated meningitis and ventriculitis-a single center cohort study. Infect Dis Rep. 2022;14(3):420–427. doi:10.3390/idr14030045
  • Chen C, Zhang B, Yu S, et al. The incidence and risk factors of meningitis after major craniotomy in China: a retrospective cohort study. PLoS One. 2014;9(7):e101961. doi:10.1371/journal.pone.0101961
  • Rogers T, Sok K, Erickson T, et al. The comparison of gram-positive and gram-negative healthcare-associated ventriculitis and meningitis in adults and children. Intensive Care Med. 2020;46(1):128–131. doi:10.1007/s00134-019-05815-7
  • Kurtaran B, Kuscu F, Ulu A, et al. The causes of post-operative meningitis: the comparison of gram-negative and gram-positive pathogens. Turk Neurosurg. 2018;28(4):589–596. doi:10.5137/1019-5149.JTN.20575-17.1
  • Mehreen SF, Padmaja K, Sudhaharan S, Teja VD, Saradhi MV, Krishna YV. Clinical and microbiological spectrum of external ventricular drain related infections (EVDRIs) from a tertiary care center. Iran J Microbiol. 2022;14(2):168–173. doi:10.18502/ijm.v14i2.9183
  • Munari M, Franzoi F, Sergi M, et al. Extensively drug-resistant and multidrug-resistant gram-negative pathogens in the neurocritical intensive care unit. Acta Neurochir. 2022;164(3):859–865. doi:10.1007/s00701-020-04611-3
  • Pandey S, Li L, Deng XY, Cui DM, Gao L. Outcome following the treatment of ventriculitis caused by multi/extensive drug resistance gram negative Bacilli; Acinetobacter baumannii and Klebsiella pneumonia. Front Neurol. 2019;9:1174. doi:10.3389/fneur.2018.01174
  • Karvouniaris M, Brotis A, Tsiakos K, Palli E, Koulenti D. Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis. Infect Drug Resist. 2022;15:697–721. doi:10.2147/IDR.S326456
  • Wang Q, Wang X, Wang J. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy660
  • Khalaveh F, Fazel N, Mischkulnig M. Risk factors promoting external ventricular drain infections in adult neurosurgical patients at the intensive care unit—a retrospective study. Front Neurol. 2021;12:734156. doi:10.3389/fneur.2021.734156
  • Dakson A, Kameda-Smith M, Staudt MD, et al. A nationwide prospective multicenter study of external ventricular drainage: accuracy, safety, and related complications. J Neurosurg. 2021;26:1–9.
  • Zhu Y, Wen L, You W. Influence of ward environments on external ventricular drain infections: a retrospective risk factor analysis. Surg Infect. 2021;22(2):211–216. doi:10.1089/sur.2019.355
  • Sweid A, Weinberg JH, Abbas R. Predictors of ventriculostomy infection in a large single-center cohort. J Neurosurg. 2020;134(3):1218–1225. doi:10.3171/2020.2.JNS192051
  • Kim J, Lee J, Feng R. Ventricular catheter tract hemorrhage as a risk factor for ventriculostomy-related infection. Oper Neurosurg. 2020;18(1):69–74. doi:10.1093/ons/opz148
  • Sam J, Lim C, Sharda P, Wahab N. The organisms and factors affecting outcomes of external ventricular drainage catheter-related ventriculitis: a Penang experience. Asian J Neurosurg. 2018;13(2):250–257. doi:10.4103/ajns.AJNS_150_16
  • Hussein K, Rabino G, Feder O. Risk factors for meningitis in neurosurgical patients with cerebrospinal fluid drains: prospective observational cohort study. Acta Neurochir. 2019;161(3):517–524. doi:10.1007/s00701-019-03801-y
  • Kohli G, Singh R, Herschman Y, Mammis A. Infection incidence associated with external ventriculostomy placement: a comparison of outcomes in the emergency department, intensive care unit, and operating room. World Neurosurg. 2018;110:e135–e140. doi:10.1016/j.wneu.2017.10.129
  • Phan K, Schultz K, Huang C. External ventricular drain infections at the Canberra Hospital: a retrospective study. J Clin Neurosci. 2016;32:95–98. doi:10.1016/j.jocn.2016.03.019
  • Atkinson R, Fikrey L, Jones A, Pringle C, Patel HC. Cerebrospinal fluid infection associated with silver-impregnated external ventricular drain catheters. World Neurosurg. 2016;89:505–509. doi:10.1016/j.wneu.2016.01.034
  • Corsini Campioli C, Challener D, Comba IY. Overview and risk factors for postcraniotomy surgical site infection: a four-year experience. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e14. doi:10.1017/ash.2021.258
  • Jiménez-Martínez E, Cuervo G, Hornero A. Risk factors for surgical site infection after craniotomy: a prospective cohort study. Antimicrob Resist Infect Control. 2019;8(1):69. doi:10.1186/s13756-019-0525-3
  • Wang L-Y, Cao X-H, Shi L-K, Ma -Z-Z, Wang Y, Liu Y. Risk factors for intracranial infection after craniotomy: a case-control study. Brain Behav. 2020;10(7):e01658. doi:10.1002/brb3.1658
  • Kuwano A, Saito T, Nitta M, et al. Relationship between characteristics of glioma treatment and surgical site infections. Acta Neurochir. 2022;165(3):659–666.
  • Maye H, Colombo F, Bourama E, et al. Does the use of surgical adjuncts affect postoperative infection rates in neuro-oncology surgery? World Neurosurg. 2022;162:e246–e250. doi:10.1016/j.wneu.2022.02.124
  • Caruso JP, Griffin S, El Ahmadieh TY. Surgical site infection after autologous cranioplasty for decompressive craniectomy in traumatic brain injury: a retrospective review of two level 1 trauma centers. J Craniofac Surg. 2021;32(8):2728–2731. doi:10.1097/SCS.0000000000007830
  • Alkhaibary A, Alharbi A, Abbas M. Predictors of surgical site infection in autologous cranioplasty: a retrospective analysis of subcutaneously preserved bone flaps in abdominal pockets. World Neurosurg. 2020;133:e627–e632. doi:10.1016/j.wneu.2019.09.120
  • Valentini L, Chiaffarino F, Bonfanti N, et al. Incidence and risk factors of neurosurgical site infections: results of a prospective multicenter cohort study on 6359 surgeries. J Neurosurg Sci. 2021;65(1):24–32. doi:10.23736/S0390-5616.18.04322-9
  • Shi Z-H, Xu M, Wang Y-Z. Post-craniotomy intracranial infection in patients with brain tumors: a retrospective analysis of 5723 consecutive patients. Br J Neurosurg. 2017;31(1):5–9. doi:10.1080/02688697.2016.1253827
  • Shi Y-J, Zheng G-H, Qian L-Y, Qsman RA, Li -G-G, Zhang G-J. Longitudinal analysis of risk factors for clinical outcomes of Enterobacteriaceae meningitis/Encephalitis in post-neurosurgical patients: a comparative cohort study during 2014–2019. Infect Drug Resist. 2020;13:2161–2170. doi:10.2147/IDR.S252331
  • Zheng G, Shi Y, Cao Y. Clinical feature, therapy, antimicrobial resistance gene distribution, and outcome of nosocomial meningitis induced by multidrug-resistant Enterobacteriaceae-a longitudinal cohort study from two neurosurgical centers in Northern China. Front Cell Infect Microbiol. 2022;12:839257. doi:10.3389/fcimb.2022.839257
  • Guanghui Z, Jing L, Guojun Z, Hong L. Epidemiology and risk factors of neurosurgical bacterial meningitis/encephalitis induced by carbapenem resistant Enterobacteriaceae. J Infect Chemother. 2020;26(1):101–106. doi:10.1016/j.jiac.2019.07.023
  • Baheerathan A, Pitceathly RD, Curtis C, Davies NW. CSF lactate. Pract Neurol. 2020;20(4):320–323. doi:10.1136/practneurol-2019-002191
  • Velissaris D, Pintea M, Pantzaris N, et al. The role of procalcitonin in the diagnosis of meningitis: a literature review. J Clin Med. 2018;7(6):148. doi:10.3390/jcm7060148
  • Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543(7643):15. doi:10.1038/nature.2017.21550
  • Iovleva A, Doi Y. Carbapenem-Resistant Enterobacteriaceae. Clin Lab Med. 2017;37(2):303–315. doi:10.1016/j.cll.2017.01.005
  • Suay-García B, Pérez-Gracia MT. Present and future of Carbapenem-resistant Enterobacteriaceae (CRE) infections. Antibiotics. 2019;8(3):122. doi:10.3390/antibiotics8030122
  • Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect Dis. 2017;17(1):279. doi:10.1186/s12879-017-2383-z
  • Mermer S, Aydemir S, Ozgiray E, Sipahi OR. Carbapenem-resistant Klebsiella pneumoniae meningitis: a case report. J Chemother. 2016;28(5):454–455. doi:10.1179/1973947815Y.0000000020
  • Patrial YC, Tortorelli LP, Rodrigues ACS. Post-neurosurgical meningitis caused by KPC-producing Klebsiella pneumoniae: report of two cases. Rev Inst Med Trop Sao Paulo. 2019;61:e69. doi:10.1590/s1678-9946201961069
  • He Z, Wang C, Liu B, et al. Successful treatment of serious meningitis caused by extremely carbapenem-resistant Enterobacter cloacae (MIC≥16mg/L) with i.v. meropenem and i.v. amikacin plus intraventricular amikacin. Infect Drug Resist. 2019;12:3765–3770. doi:10.2147/IDR.S224509
  • Li J, Liu Y, Wu G, et al. Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: a case report. Medicine. 2022;101(30):e29635. doi:10.1097/MD.0000000000029635
  • Zhou M, Liang R, Liao Q, et al. Lumbar cistern drainage and gentamicin intrathecal injection in the treatment of carbapenem-resistant Klebsiella Pneumoniae intracranial infection after intracerebral hemorrhage craniotomy: a case report. Infect Drug Resist. 2022;15:6975–6983. doi:10.2147/IDR.S378753
  • Sheu -C-C, Chang Y-T, Lin S-Y, Chen Y-H, Hsueh P-R. Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options. Front Microbiol. 2019;10:80. doi:10.3389/fmicb.2019.00080
  • Yue C, Lei L. The treatment of nosocomial meningitis and brain abscess by carbapenem-resistant Klebsiella pneumonia. Br J Neurosurg. 2019;25:1–3.
  • Pektezel MY, Isikay I, Gocmen R, Inkaya AC. Carbapenem-resistant Klebsiella pneumoniae meningitis and abscess treated with ceftazidime-avibactam. Enferm Infecc Microbiol Clin. 2022;40(6):332–333. doi:10.1016/j.eimc.2021.03.014
  • Holyk A, Belden V, Lee JJ. Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report. J Antimicrob Chemother. 2018;73(1):254–256. doi:10.1093/jac/dkx358
  • Gofman N, To K, Whitman M, Garcia-Morales E. Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime–avibactam and intrathecal amikacin. Am J Health Syst Pharm. 2018;75(13):953–957. doi:10.2146/ajhp170632
  • Yasmin M, Hanrahan J, Marshall S. Using therapeutic drug monitoring to treat KPC-producing Klebsiella pneumoniae central nervous system infection with ceftazidime/avibactam. Open Forum Infect Dis. 2020;7(9):ofaa349. doi:10.1093/ofid/ofaa349
  • De Santis LB, Gómez IM, Díaz BS, et al. Nosocomial meningitis caused by ESBL- and OXA-48-producing Klebsiella pneumoniae and treated with ceftazidime-avibactam. Report of one case and review of the literature. Rev Esp Quimioter. 2022;35(6):572–576. doi:10.37201/req/043.2022
  • Gatti M, Virgili G, Cojutti PG. Real-time optimization of pharmacodynamic target attainment at infection site during treatment of post-neurosurgical ventriculitis caused by carbapenem-resistant gram negatives with ceftazidime-avibactam-based regimens: a report of two cases. Microorganisms. 2022;10(1):154. doi:10.3390/microorganisms10010154
  • Ackley R, Roshdy D, Meredith J. Meropenem-vaborbactam versus ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae infections. Antimicrob Agents Chemother. 2020;64(5):e02313–e02319. doi:10.1128/AAC.02313-19
  • Castanheira M, Davis AP, Mendes RE, Serio AW, Krause KM, Flamm RK. In vitro activity of plazomicin against gram-negative and gram-positive isolates collected from U.S. hospitals and comparative activities of aminoglycosides against carbapenem-resistant Enterobacteriaceae and isolates carrying carbapenemase genes. Antimicrob Agents Chemother. 2018;62(8):e00313–e00318. doi:10.1128/AAC.00313-18
  • Zhanel GG, Cheung D, Adam H. Review of eravacycline, a novel fluorocycline antibacterial agent. Drugs. 2016;76(5):567–588. doi:10.1007/s40265-016-0545-8
  • Ito A, Nishikawa T, Matsumoto S. Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2016;60(12):7396–7401. doi:10.1128/AAC.01405-16
  • Wright H, Bonomo RA, Paterson DL, et al. New agents for the treatment of infections with gram-negative bacteria: restoring the miracle or false dawn? Clin Microbiol Infect. 2017;23(10):704–712. doi:10.1016/j.cmi.2017.09.001
  • Colombo F, Waheed A, Panese S. Treatment with cefiderocol in K. pneumoniae KPC nosocomial external ventricular drainage meningitis: a brief report. Infez Med. 2022;30(3):454–458. doi:10.53854/liim-3003-15
  • Kufel WD, Abouelhassan Y, Steele JM. Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis. J Antimicrob Chemother. 2022;77(10):2737–2741. doi:10.1093/jac/dkac248
  • Stevenson DR, Cherian BP, Kinzig M, Sörgel F, Wareham DW. Intravenous cefiderocol for neurosurgical meningitis from an extensively drug-resistant New-Delhi metallo-β-lactamase-producing Pseudomonas aeruginosa strain. J Glob Antimicrob Resist. 2023;32:29–30. doi:10.1016/j.jgar.2022.11.019
  • Tunkel AR, Hasbun R, Bhimraj A. 2017 infectious diseases society of america’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34–e65. doi:10.1093/cid/ciw861
  • Bargiacchi O, De Rosa FG. Intrathecal or intraventricular colistin: a review. Infez Med. 2016;24(1):3–11.
  • Nau R, Blei C, Eiffert H. Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev. 2020;33(3):e00190–e00219. doi:10.1128/CMR.00190-19
  • Zheng G, Cao Y, Liu C. Phenotype, molecular characterisation and risk factors for postoperative meningitis caused by ESBL-producing-Enterobacteriaceae: a six years multi-centre comparative cohort study. BMC Infect Dis. 2021;21(1):85. doi:10.1186/s12879-021-05784-7